Categories
Aurobindo Pharma Limited — Updates, 24-05-2026: General Updates
24-05-2026 · 05:38 pm
Aurobindo Pharma's subsidiary, Eugia Pharma, had its Unit-I manufacturing facility classified as "Official Action Indicated" (OAI) by the US FDA, following 4 observations. The company confirmed no financial or operational impact from this action.
No comments yet. Be the first to comment!